SFM
ABMD

Soros Fund Management’s Abiomed Inc ABMD Stock Holding History

Soros Fund Management’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-2,400
Closed -$300K – 322
2017
Q1 		$300K Buy
+2,400
New +$278K 0.01% 204

Other funds holding ABMD

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Soros Fund Management's ABMD Position: Q2 2017 in Review

Soros Fund Management sold out of Abiomed Inc (ABMD) in Q2 2017, closing a stake of 2,400 shares — an estimated $300K sold.

Soros Fund Management first reported a position in ABMD in Q1 2017 and held it in 1 quarter. The position peaked at $300K in Q1 2017. 303 funds tracked by Wall St. Rank hold ABMD as of Q2 2017.

  • Soros Fund Management reported no remaining Abiomed Inc position as of Q2 2017 after selling out during the quarter.
  • Soros Fund Management sold 2,400 Abiomed Inc shares in Q2 2017, an estimated $300K.
  • Soros Fund Management first reported a position in Abiomed Inc in Q1 2017 and held it in 1 quarter.
  • Soros Fund Management's Abiomed Inc position peaked at $300K in Q1 2017.
  • 303 funds tracked by Wall St. Rank held Abiomed Inc as of Q2 2017.

Based on Soros Fund Management's 13F filing for Q2 2017, filed 14 Aug 2017.